Abstract:e15506 Background: Colorectal cancer (CRC) is one of the most common types of malignant tumors, and its incidence is increasing year by year.Chemokines are small cytokines or signaling proteins secreted by cells. They have the ability to induce directional chemotactic migration of nearby responding cells and can mediate intracellular signal transduction by binding to 18 G protein-coupled receptor families.C-X-C motif chemokine receptor 3 (CXCR3) is activated by three Interferon-γ inducible ligands CXCL9, CXCL10 and CXCL11 and encodes 368 amino acids. Its molecular weight was about 41KDa and the cDNA was 1104bp in length.In recent years, a large number of studies have confirmed that the expression of CXCR3 and its ligands in the body is closely related to tumor immunity, tumorigenesis and metastasis.Therefore, the aim of this study is to investigate the expression of CXCR3 in tumor and adjacent intestinal tissues of patients with colorectal cancer and the effects of related gene detection on tumor proliferation, migration, invasion and recurrence in patients with colorectal cancer. Methods: Flow cytometry was used to detect 40 colon cancer patients who had not received neoadjuvant therapy in the Department of General Surgery of the Affiliated Cancer Hospital of Zhengzhou University. The expression of CXCR3, PD-1, CD4+, CD45+ and CD8+T cells in tumor and para-tumor specimens (taken > 2cm from the edge of the cancer) was detected, and the expression characteristics of CXCR3 in colon cancer patients and its correlation with general clinical data were analyzed. The correlation between KRAS, MSS, MSI-H gene mutations and colon cancer was analyzed under the condition of different lymphocyte expression. Results: 1.CXCR3+CD8+T cells were significantly different, and CXCR3+CD4+T cells were significantly different. These results suggest that CXCR3 expression with different lymphocytes may play an important role in tumor cell growth.2.The difference of CD45+T cells was statistically significant. This suggests that the expression of CD45+T cells may also affect tumor growth.3.CXCR3+CD4+T cells may play a role in promoting tumor metastasis. Conclusions: The expression of CXCR3+CD8+T cells, CXCR3+CD4+T cells and CD45+T lymphocytes in tumor tissues of colon cancer patients is correlated with the expression of adjacent tissues. The expression of PD-1+CD8+ lymphocytes in tumor tissues is less than that in adjacent tissues, indicating that they are related to tumor metastasis and proliferation. CXCR3 may play an important role in lymph node metastasis, and PD-1 expression may also be related to patient gender. Therefore, the expression of CXCR3 and T lymphocytes in tumor tissues and adjacent tissues of patients is helpful for the diagnosis and treatment of colon cancer, and has important value in clinical application.

Transfection of Colorectal Cancer Cells with Chemokine MCP-3 (monocyte Chemotactic Protein-3) Gene Retards Tumor Growth and Inhibits Tumor Metastasis

[Active Immunity for Anti-Colorectal Cancer Induced by Chemokine MCP-3 Gene Transfection].

Co-Transfection of Colorectal Cancer Cells with Chemokine MCP-3 Gene and B7 Gene to Induce Anti-Tumor Immunity

Significant Reduction of T-cell Chemotaxis to MCP-1 in Patients with Primary and Metastatic Melanoma.

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

MEG 3 regulates the invasion and migration of lung cancer via targeting miR-219 a and through MAPK pathway

Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

CCL3 Promotes Proliferation of Colorectal Cancer

Dendritic Cell-Targeting Chemokines Inhibit Colorectal Cancer Progression

Targeting Tumor-Expressing CCR6 Inhibits Colorectal Cancer Progression in Mice (127.44)

Expression of Chemokine MCP-1 in Colorectal Carcinoma and its Relationship with the Infiltration of Immunocyte

Mir-338-3p Suppresses Colorectal Cancer Proliferation and Progression by Inhibiting MACC1.

The Effect of Monocyte Chemotactic Protein-1(MCP-1)in Nude Bearing Human Transitional Cell Cancer of Bladder

CMTM3 As a Potential New Immune Checkpoint Regulator

The Expression of Chemokine MCP-1 in Colorectal Carcinoma and Its Relationship to the Infiltration of Macrophage

Administration of MIP-3alpha Gene to the Tumor Following Radiation Therapy Boosts Anti-Tumor Immunity in a Murine Model of Lung Carcinoma.

Study on the Mechanism of CXCR3 Expression in Paracancer and Tumor Tissues of Colon Cancer Patients

CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway

Effect of Bone Marrow-Derived Monocytes Transfected with Rna of Mouse Colon Carcinoma on Specific Antitumor Immunity

Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells

Big Tumor Regression Induced by Gm-Csf Gene-Modified 3ll Tumor Cells Via Facilitating Dc Maturation and Deviation Toward Cd11c(+)Cd8 Alpha(+) Subset